Simplifying Global Compliance
Impax to Sell Generic Renvela, Renagel in 2014 After Genzyme Settlement
Washington Drug Letter
Impax Laboratories can market generic versions of Genzyme’s kidney disease drugs Renvela and Renagel in 2014 under a settlement with the brand drugmaker.
To View This Article:
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing